Longer length of stay, comorbidity linked to IBD rehospitalization

  • Cohen-Mekelburg S & al.
  • Am J Manag Care
  • 01.10.2019

  • von Craig Hicks
  • Clinical Essentials
Der Zugang zum gesamten Inhalt dieser Seite ist nur Angehörigen medizinischer Fachkreise vorbehalten. Der Zugang zum gesamten Inhalt dieser Seite ist nur Angehörigen medizinischer Fachkreise vorbehalten.

Takeaway

  • Nearly 1 in 7 patients hospitalized for IBD are readmitted within 30 days of the initial discharge.

Why this matters

  • Hospital care accounts for up to one-third of the IBD management costs.

Study design

  • Researchers studied the health records of patients admitted to hospitals in 2 states (New York, 19,559 patients; Florida, 19,676 patients) for IBD treatment to determine the prevalence of 30-day IBD-specific readmission.
  • Funding: None.

Key results

  • 13.7%-16.2% of the IBD-related stays resulted in a 30-day readmission.
  • 30-day readmissions were associated with a longer length of stay than index hospitalizations by 1.00 day (adjusted regression coefficient, 1.00; 95% CI, 0.73-1.26).
  • They also were associated with a higher likelihood of having a comorbid condition:
    • New York: aOR, 1.83; 95% CI, 1.68-1.99.
    • Florida: aOR, 1.79; 95% CI, 1.64-1.95.

Limitations

  • The study was retrospective, subject to misclassification bias, and did not assess causality.